Stockreport

Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results [Yahoo! Finance]

Praxis Precision Medicines, Inc.  (PRAX) 
PDF BOSTON, July 29, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into th [Read more]